Clinical Trials Logo

Filter by:
NCT ID: NCT00300807 Active, not recruiting - Hepatitis C Clinical Trials

Study of XTL6865 in Patients With Chronic Hepatitis C Virus Infection

Start date: October 2005
Phase: Phase 1
Study type: Interventional

1. Evaluate the safety, tolerability, and virologic activity of escalating single (and multiple) doses of XTL6865, a mixture (1:1) of two human monoclonal antibodies (HCV-AbXTL68 and HCV-AbXTL65), in patients with chronic hepatitis C virus infection. 2. Assess the pharmacokinetics of XTL6865 in the presence and absence of viral infection.

NCT ID: NCT00300313 Completed - Clinical trials for Post-traumatic Stress Disorder

PTSD Prevention Using Escitalopram

Start date: June 2005
Phase: N/A
Study type: Interventional

Assessing the efficacy of escitalopram in preventing the development of PTSD, or or reducing its severeness, after exposure to a traumatic event.

NCT ID: NCT00300196 Terminated - Stroke Clinical Trials

ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Start date: March 2006
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to determine whether a brief intravenous infusion of ancrod started within 6 hours of stroke onset improves functional outcome at 3 months.

NCT ID: NCT00299910 Recruiting - Clinical trials for Sleep Disordered Breathing

Inflammatory Response to Anti Inflammatory Therapy in Children With Sleep Disordered Breathing

Start date: March 2005
Phase: Phase 4
Study type: Interventional

This study will assess in a double blind placebo controlled fashion the effects of a 12 week course of oral montelukast/placebo on polysomnographic and radiological findings and will characterize the systemic (serum,urine) and local (upper airway collected biological samples) inflammatory response in children (2-10 years of age) with sleep disordered breathing, fittingthe inclusion and exclusion criteria.

NCT ID: NCT00299663 Completed - Clinical trials for Streptococcal Infections

Long Term Follow-up of Patients With Group A Streptococcal Infection Originating From the Genital Tract

Start date: February 2006
Phase: N/A
Study type: Observational

Group A streptococcus (GAS) causes a variety of human infections. It is also an uncommon but serious cause of postpartum infections. In contrast to group B streptococcus (GBS) infection, which causes illness and death in newborns disproportionately more often than it does in mothers, perinatal GAS infection primarily affects mothers . Invasive GAS infection is defined by the isolation of GAS from a normally sterile site (e.g., blood) or by the isolation of GAS from a nonsterile site in the presence of the streptococcal toxic shock syndrome or necrotizing fasciitis. A postpartum case of invasive GAS is defined as isolation of GAS during the postpartum period, in association with a clinical postpartum infection (e.g., endometritis) or from either a sterile site or a wound infection. Because of the burden and severity of invasive GAS infection, the Centers for Disease Control and Prevention (CDC) hosted a meeting in to formulate guidelines for responding to postpartum and postsurgical GAS infections. However, we could not find any recommendations for long-term follow-up of patients who had GAS infection subsequent to delivery or gynaecological procedures, or further recommendations regarding subsequent delivery or gynaecological invasive procedures. It is possible that women who had GAS as a cause of vaginal infection may have a tendency to be carriers of this organism, but this has never been proven. We believe it is of importance to determine if women who have had one infection may be long-term carriers which may pose a risk during future pregnancies. The objective of the present study is to evaluate the incidence of long term gynaecological carrier state of patients who had GAS invasive infection following delivery, and to provide guidelines for follow-up and treatment of such patients. The proposed study may answer the question whether this endogenous GAS origin represents chronic GAS carrier state, similar to the known GBS carrier state. As some of these patients had severe infections (sometimes life threatening) a protocol for long-term follow up and management is necessary in case an invasive procedure is done (IUD insertion, endometrial biopsy, curettage or delivery) in order to prevent recurrent infection. The information collected in the study will enable us to afford recommendations for follow up and prophylaxis in the future.

NCT ID: NCT00299637 Recruiting - Chorioamnionitis Clinical Trials

Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical Chorioamnionitis

Start date: October 2006
Phase: Phase 0
Study type: Observational

This study will try to determine whether fetuses to mothers having clinical chorioamnionitis have changes in blood flow in middle cerebral artery.

NCT ID: NCT00299598 Completed - Oral Health Clinical Trials

Clinical Study of Antibacterial Nanoparticles Incorporated in Composite Restorations

Start date: September 2006
Phase: Phase 2
Study type: Observational

Resin composites withholding antibacterial properties may be useful in preventing recurrent caries. Covalently attached antibacterial polymers are a possible solution.This in vivo study would evaluated the antibacterial effect of alkylated polyethylenimine nanoparticles incorporated into flowable and hybrid composite resin disks embedded in a palatal removable appliance.The disks would be in close contact with the palate in order to check for contact mucosities. disks on the side facing the Tongue would be evaluated for their antibacterial potency with confocal laser scanning microscopy.

NCT ID: NCT00299585 Suspended - Dental Implants Clinical Trials

A Clinical Study of the Use of Brushite as Primary Stabilizer in Immediate Dental Implantation

Start date: December 2007
Phase: Phase 2
Study type: Interventional

Objective: The evaluation of "PD" VitalOs Cement, an injectable brushite, as a stabilizer of dental implants and a potential source for bone augmentation. Methods: Forty (40) patients needing dental implants will be treated where needed with "PD" VitalOs Cement gapping half of their sites whereas the other half will be gapped with Bio-oss demineralized bone and BioGuide membrane.

NCT ID: NCT00299013 Completed - Ulcerative Colitis Clinical Trials

Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis

Start date: March 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate whether a novel dosage form of a prednisolone ester, called COLAL-PRED®, is useful in the treatment of ulcerative colitis.

NCT ID: NCT00298961 Not yet recruiting - Remote Consultation Clinical Trials

Psychiatric Consultation Through Videoconference in a Primary Care Setting

Start date: May 2006
Phase: N/A
Study type: Interventional

In our study we will aim to examine the issues of cost analysis, quality of life, clinical efficacy and satisfaction of psychiatric consultations through videoconference in a primary care setting in comparison with in-person psychiatric treatment and primary care only. The main hypotheses of the study are: Satisfaction of the patients will increase, the use of telepsychiatry will reduce the costs for the primary and mental health care centers as well as for the patients, the treatment will be as effective as in-person treatment, the number of patients referred to mental health treatment will be higher than that of the previous year, quality of life will improve and that there will be a stigma reduction of mental illness.